Overview
Intrinsic factor IgG antibody testing is used to detect autoantibodies directed against intrinsic factor, a glycoprotein produced by the parietal cells of the gastric mucosa. Intrinsic factor is essential for the absorption of vitamin B12 in the terminal ileum. When antibodies develop against intrinsic factor, vitamin B12 absorption is impaired, leading to deficiency and the development of pernicious anemia.
Intrinsic factor antibodies are proteins produced by the immune system and are strongly associated with autoimmune gastritis and pernicious anemia. Estimation of serum intrinsic factor IgG antibodies plays a crucial role in confirming the autoimmune etiology of vitamin B12 deficiency and distinguishing pernicious anemia from other causes of megaloblastic anemia.
Pathophysiology
Gastric parietal cells secrete intrinsic factor under the stimulation of histamine, gastrin, and acetylcholine. Intrinsic factor binds dietary vitamin B12 and facilitates its absorption in the small intestine.
In certain individuals, an autoimmune response develops against intrinsic factor or against the intrinsic factor–producing parietal cells. These antibodies interfere with intrinsic factor function and damage the cells responsible for its secretion. As a result, intrinsic factor levels fall, leading to impaired vitamin B12 absorption.
This deficiency of cobalamin disrupts DNA synthesis, particularly in rapidly dividing cells such as those in the bone marrow. The consequence is megaloblastic anemia along with neurological and gastrointestinal manifestations characteristic of pernicious anemia.
Types of Intrinsic Factor Antibodies
Two major types of intrinsic factor antibodies are described. Blocking antibodies prevent vitamin B12 from binding to intrinsic factor. This directly inhibits formation of the vitamin B12–intrinsic factor complex.
Binding antibodies interfere with the absorption of the vitamin B12–intrinsic factor complex in the terminal ileum. Both types ultimately result in reduced vitamin B12 availability despite adequate dietary intake.
Clinical Manifestations
Clinical features arise due to vitamin B12 deficiency and autoimmune gastric involvement. Common symptoms include fatigue and generalized weakness.
Glossitis is frequently observed and presents as a smooth, inflamed tongue. Neurological manifestations include peripheral neuritis, tingling, numbness, paresthesia, and ataxia due to demyelination of peripheral nerves and the spinal cord.
Patients may also have autoimmune gastritis and develop megaloblastic anemia. If left untreated, neurological damage may become irreversible.
Indications for Testing
Intrinsic factor IgG antibody testing is indicated in patients with suspected or confirmed pernicious anemia. It is useful in individuals with autoimmune conditions affecting the stomach.
The test is recommended in cases of megaloblastic anemia with no identifiable cause and in patients with unexplained macrocytic anemia. It is also indicated in patients presenting with neuropathy, neurological symptoms, or low serum vitamin B12 levels without an obvious dietary deficiency.
Assay Methods
Intrinsic factor IgG antibodies are detected using immunological techniques. Qualitative enzyme-linked immunosorbent assay (ELISA) is the most commonly used method.
Radioimmunoassay may also be used in selected laboratories. These assays detect the presence of antibodies directed against intrinsic factor and provide qualitative or semi-quantitative results.
Sample Collection and Handling
For testing, 3.0 mL of blood is collected in a plain red-capped tube. Serum should be separated as early as possible to preserve sample integrity.
The sample should be sent to the laboratory immediately at ambient temperature. Grossly hemolyzed or lipemic samples should be rejected as they may interfere with assay accuracy. For longer storage, frozen serum samples are preferred.
Reference Range
Results are reported based on antibody concentration. A value less than 1.20 AU/mL is considered negative.
Values between 1.21 and 1.52 AU/mL are considered equivocal and may require repeat testing or clinical correlation. A value greater than 1.53 AU/mL is considered positive for intrinsic factor IgG antibodies.
Interpretation of Results
A positive intrinsic factor antibody test strongly suggests pernicious anemia. The test has a very high specificity of more than 95%, making a positive result highly diagnostic.
However, sensitivity is moderate, ranging from 50% to 70%. This means that a negative test does not exclude pernicious anemia, especially in early disease or in patients with parietal cell–predominant autoimmunity.
Results must always be interpreted in conjunction with clinical findings, complete blood count, peripheral smear, serum vitamin B12 levels, and other autoimmune markers.
Role of the Schilling Test
The Schilling test was historically used to assess vitamin B12 absorption and determine the cause of deficiency by administering radioactive vitamin B12 with and without intrinsic factor.
Due to advances in immunological and biochemical testing, the Schilling test is now obsolete and largely abandoned. Intrinsic factor antibody testing has replaced it as a more practical and reliable diagnostic tool.
Clinical Utility
Intrinsic factor IgG antibody testing is an essential investigation in the diagnosis of pernicious anemia. It helps confirm autoimmune vitamin B12 malabsorption and guides long-term management.
Early diagnosis allows timely vitamin B12 replacement, preventing irreversible neurological damage and improving patient outcomes.
